Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px

Deals > All

Total search results: 9895 | Ordered by Date (descending)
1 2 3 ... 97 98 99  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Amal Therapeutics–Boehringer: investment, 201907 acquisition of Amal by Boehringer for up to €325m 2019-07-15
Ncardia–Evotec: investment, 201907 acquisition €na of iPSC assets + 17 strong team of bankrupt Ncardia AG in Cologne 2019-07-15
Recursion Pharmaceuticals–SEVERAL: investment, 201907 financing round Series C $121m led by Baillie Gifford 2019-07-15
Galapagos–Gilead: investment, 201907 equity investment $1.1b at €140.59/share raising share from 12.3% to 22% as part of collab 2019-07-14
Gilead–Galapagos: drug research + development, 201907–202906 strategic 10y collab $3.9b upfront + $1.1b equity investment + milestones 2019-07-14
Genmab–Blink Biomedical: therapeutic antibodies, 201907– license to use CD47 Abs in DuoBodies $2.25m upfront + up to $200m per product plus royalties 2019-07-12
BioTek Instruments–Agilent: investment, 201907– acquisition $1.165b incl anticipated tax benefits net $1.05b 2019-07-11
Microphyt–CEA Industrie: investment, 201907 financing round totalling €28.5m incl existing + co-investor Supernova Invest 2019-07-11
Microphyt–Demeter: investment, 201907 financing round totalling €28.5m incl existing + co-investor Demeter Partners 2019-07-11
Microphyt–France (govt): investment, 201907 financing round totalling €28.5m incl new + co-lead investor Bpifrance SPI Fund 2019-07-11
Microphyt–Irdi Soridec: investment, 201907 financing round totalling €28.5m incl existing + co-investor Irdi Soridec 2019-07-11
Microphyt–iXO Private Equity: investment, 201907 financing round totalling €28.5m incl new + co-investor iXO Private Equity 2019-07-11
Microphyt–Safilaro: investment, 201907 financing round totalling €28.5m incl new + co-investor Sofilaro 2019-07-11
Microphyt–SEVERAL: investment, 201907 financing round €28.5m co-led by Sofinnova Partners + Bpifrance SPI Fund 2019-07-11
Microphyt–Sofinnova: investment, 201907 financing round totalling €28.5m incl new + co-lead investor Sofinnova Partners 2019-07-11
Vasopharm–Bavaria (govt): investment, 201907 financing round totalling €9.5m incl existing + co-investor Bayern Kapital 2019-07-11
Vasopharm–Creathor Ventures: investment, 201907 financing round totalling €9.5m incl new + co-investor Creathor Ventures 2019-07-11
Vasopharm–EF Investments: investment, 201907 financing round totalling €9.5m incl co-lead investor EF Investments 2019-07-11
Vasopharm–HeidelbergCapital: investment, 201907 financing round totalling €9.5m incl existing + co-lead investor HeidelbergCapital Private Equity 2019-07-11
Vasopharm–Hessen (govt): investment, 201907 financing round totalling €9.5m incl existing + co-investor Future Capital 2019-07-11
Vasopharm–Optimum Strategic Communications: public relations, 201907 service existent by Optimum 2019-07-11
Vasopharm–SEVERAL: investment, 201907 financing round €9.5m co-led by HeidelbergCapital Private Equity + EF Investments 2019-07-11
Start Codon–Zyme Communications: public relations, 201907 service existent by Zyme 2019-07-10
BioNTech–BVCF Management: investment, 201907 financing round Series B totalling $325m incl co-investor BVCF Management 2019-07-09
BioNTech–Fidelity: investment, 201907 financing round Series B totalling $325m incl existing + lead investor Fidelity Management and Research 2019-07-09
BioNTech–Invus Group: investment, 201907 financing round Series B totalling $325m incl existing + co-investor Invus 2019-07-09
BioNTech–Jebsen Capital: investment, 201907 financing round Series B totalling $325m incl co-investor Jebsen Capital 2019-07-09
BioNTech–Mirae Asset: investment, 201907 financing round Series B totalling $325m incl co-investor Mirae Asset Financial Group 2019-07-09
BioNTech–Platinum Asset Management: investment, 201907 financing round Series B totalling $325m incl co-investor Platinum Asset Management 2019-07-09
BioNTech–Redmile Group: investment, 201907 financing round Series B totalling $325m incl existing + co-investor Redmile Group 2019-07-09
BioNTech–SEVERAL: investment, 201907 financing round Series B $325m led by existing investor Fidelity Management and Research 2019-07-09
BioNTech–Steam Athena Capital: investment, 201907 financing round Series B totalling $325m incl co-investor Steam Athena Capital 2019-07-09
BioNTech–Strüngmann Group: investment, 201907 financing round Series B totalling $325m incl existing + co-investorStrüngmann Family Office 2019-07-09
Revolution Medicines–Casdin Capital: investment, 201907 financing round Series C totalling $100m incl existing + co-investor Casdin Capital 2019-07-09
Revolution Medicines–Column Group: investment, 201907 financing round Series C totalling $100m incl existing + co-investor The Column Group 2019-07-09
Revolution Medicines–Nextech Invest: investment, 201907 financing round Series C totalling $100m incl existing + co-investor Nextech Invest 2019-07-09
Revolution Medicines–Schroders: investment, 201907 financing round Series C totalling $100m incl existing + co-investor Schroder Adveq 2019-07-09
Revolution Medicines–Third Rock Ventures: investment, 201907 financing round Series C totalling $100m incl existing + co-investor Third Rock Ventures 2019-07-09
Breakpoint Therapeutics–Evotec: investment, 201907 first financing round totalling €30m incl co-investor Evotec 2019-07-08
Breakpoint Therapeutics–Medicxi: investment, 201907 first financing round totalling €30m incl lead investor Medicxi 2019-07-08
Breakpoint Therapeutics–Otsuka: investment, 201907 first financing round totalling €30m incl co-investor Taiho Ventures LLC 2019-07-08
Breakpoint Therapeutics–SEVERAL: investment, 201907 first financing round €30m for spin-out from Evotec led by Medicxi + incl Taiho Ventures + Evotec 2019-07-08
IGM Biosciences–Haldor Topsøe: investment, 201907 financing round Series C totalling $102m incl existing + founding investor Haldor Topsøe Holding A/S 2019-07-08
IGM Biosciences–SEVERAL: investment, 201907 financing round Series C $102m incl Redmile Group + Janus Henderson + Vivo Capital et al 2019-07-08
PMOD Technologies–Bruker Corp: investment, 201907 acquisition €na of PMOD Technologies LLC by Bruker 2019-07-08
Danaher–Cobo Technologies: protein expression analysis, 201907– collab co-marketing PIPPR platform with SWATH Acquisition + Sciex TripleTOF 6600 2019-07-05
Citryll–BrightGene: investment, 201907 first closing of a targeted €15m financing round Series A incl investor BrightGene International Ltd 2019-07-03
Citryll–Curie Capital: investment, 201907 first closing of a targeted €15m financing round Series A incl investor Curie Capital 2019-07-03
Citryll–ModiQuest: investment, 201907 first closing of a targeted €15m financing round Series A incl investor ModiQuest BV 2019-07-03
Citryll–Netherlands (govt): investment, 201907 first closing of a targeted €15m financing round Series A incl investor BOM Brabant Ventures 2019-07-03
Citryll–SEVERAL: investment, 201907 first closing of targeted €15m financing round Series A with ModiQuest + BOM + BrightGene + Curie Capital 2019-07-03
Nosopharm–Evotec: antibiotics, 201907– collab €na pre-clinical developm of NOSO-502 + 2nd generation odilorhabdin 2019-07-03
Oncovita–Andrew Lloyd Associates: public relations, 201907 service existent by ALA 2019-07-02
Oncovita–Institut Pasteur: cancer immunotherapy, 201907– license excl ww €na for use of oncolytic measles virus platform for product developm + sale 2019-07-02
Oncovita–Institut Pasteur: investment, 201907 existent Institut Pasteur is shareholder of Oncovita 2019-07-02
Ahren Innovation Capital–SEVERAL: investment, 201907 closing of first fund Ahren LP in excells of £200m 2019-07-01
Antimicrobials Working Group–Entasis Therapeutics: antibiotics, 201907– collab existent Entasis is member of AWG 2019-07-01
Antimicrobials Working Group–Iterum Therapeutics: antibiotics, 201907– collab existent Iterum is member of AWG 2019-07-01
Boehringer–Yuhan: GLP1R/FGF21R agonist, 201907– collab + license agreem for FGF21 $40m upfront + $830m milestones + royalties 2019-07-01
Century Therapeutics–Bayer: investment, 201907 financing round totalling $250m commitments incl $215m from Leaps by Bayer 2019-07-01
Century Therapeutics–Fujifilm: investment, 201907 financing round totalling $250m commitments incl co-investor Fujifilm Cellular Dynamics Inc 2019-07-01
Century Therapeutics–SEVERAL: investment, 201907 financing round $250m commitments from Leaps by Bayer + Versant Ventures + Fujifilm CDI 2019-07-01
Century Therapeutics–Versant Ventures: investment, 201907 financing round totalling $250m commitments incl existing + co-investor Versant Ventures 2019-07-01
Yahong Meditech–Photocure: Cevira®, 201907– license ww developm + commercialisation to Asieris up to $250m milestones + royalties 2019-07-01
Biodesix–Oncimmune: clinical proteomic cancer test, 201906– collab excl commercialisation of EarlyCDT Lung in US by Biodesix 2019-06-28
CryoTherapeutics–SEVERAL: investment, 201906 financing round Series B €7m incl equity + debt + non-dilutive cash advances 2019-06-27
Modag–Massa Investment: investment, 201906 financing round Series A totalling €12m incl lead investor Massa Investment AG 2019-06-27
Modag–SEVERAL: investment, 201906 financing round Series A €12m led by Massa Investment AG 2019-06-27
Modag–Trophic Communications: public relations, 201906 service existent by Trophic 2019-06-27
Velabs Therapeutics–SEVERAL: investment, 201906 financing round Series B €3m 2019-06-27
Evotec–SEVERAL: credit, 201906– promissory note €250m with lead arrangers Deutsche Bank + LBBW 2019-06-26
Sanifit–Alta Life Sciences: investment, 201906 financing round Series D totalling €55.2m incl new + co-investor Alta Life Sciences 2019-06-26
Sanifit–Andera Partners: investment, 201906 financing round Series D totalling €55.2m incl existing + co-investor Andera Partners 2019-06-26
Sanifit–Columbus Venture Partners: investment, 201906 financing round Series D totalling €55.2m incl new + co-investor Columbus Venture Partners 2019-06-26
Sanifit–Consilium: public relations, 201906 service existent by CSC 2019-06-26
Sanifit–Forbion: investment, 201906 financing round Series D totalling €55.2m incl existing + co-investor Forbion Capital Partners 2019-06-26
Sanifit–Gilde Investment: investment, 201906 financing round Series D totalling €55.2m incl existing + co-investor Gilde Healthcare 2019-06-26
Sanifit–HealthEquity: investment, 201906 financing round Series D totalling €55.2m incl existing + co-investor HealthEquity 2019-06-26
Sanifit–la Caixa: investment, 201906 financing round Series D totalling €55.2m incl existing + lead investor Caixa Capital Risc 2019-06-26
Sanifit–Lundbeck: investment, 201906 financing round Series D totalling €55.2m incl existing + co-investor Lundbeckfonden Ventures 2019-06-26
Sanifit–SEVERAL: investment, 201906 financing round Series D €55.2m led by Caixa Capital Risc 2019-06-26
Sanifit–SEVERAL: investment, 201906c capitalisation of €17m of convertible bonds 2019-06-26
Sanifit–Ysios Capital: investment, 201906 financing round Series D totalling €55.2m incl existing + co-investor Ysios Capital 2019-06-26
UmanDiagnostics–Quanterix: investment, 201906–201907 acquisition $16m in cash + $6.5m in common stock 2019-06-26
Forendo Pharma–Vesalius Biocapital: investment, 201906 existent investment of Vesalius Biocapital III fund 2019-06-25
Sword Health–Vesalius Biocapital: investment, 201906 existent investment of Vesalius Biocapital III fund 2019-06-25
Transplant Genomics–Eurofins: investment, 201906 acquisition of Transplant Genomics Inc by Eurofins 2019-06-25
Vesalius Biocapital–SEVERAL: investment, 201906 final closing of €120m Vesalius Biocapital III fund 2019-06-25
SQZ Biotechnologies–Erytech: drug delivery technology, 201906– license to red blood cell encapsulation from Erytech to develop immunomodulators 2019-06-24
Terns Pharmaceuticals–Genfit: elafibranor, 201906– license excl $35m upfront + $193m milestones + royalties for Greater China 2019-06-24
Avacta–JSR Corp: cell line development, 201906– CHO cell line development for clinical manufacturing of AVA004 Affimer PD-L1 antagonist by Selexis 2019-06-20
Karolinska Institutet–BGI: DNA sequencing, 201906– collab using DNBSEQ techn for shotgun metagenomics data from microbiome biobank MGI Tech 2019-06-20
BMS–Catalent: investment, 201906– acquisition of BMS manufacturing facility in Anagni Italy by Catalent 2019-06-19
Gamida Cell–Lonza: cell therapy contract manufacturing, 201906– supply multi-year future commercial production of omidubicel by Lonza in Geleen (NL) 2019-06-19
Drax Group–Deep Branch Biotechnology: carbon recycling, 201906– collab research carbon dioxide of power generation for single cell protein production 2019-06-18
Germany (govt)–Trophic Communications: public relations, 201906 service existent for German Accelerator Life Sciences by Trophic 2019-06-18
Sanofi–Alphabet: healthcare informatics, 201906– collab new virtual innovation lab using Google Cloud for future medicines + healthcare services 2019-06-18
Spero Therapeutics–Novo Group: investment, 201906– direct offering common stock up to $10m in two tranches of $5m to Novo REPAIR Fund 2019-06-13
ADC Therapeutics–SEVERAL: investment, 201906–201907 financing round Series E expansion $103m bringing total Series E to $303m 2019-06-12
Ipsen–Debiopharm: triptorelin, 201906– strategic collab extension 15y developm + prod + distrib Decapeptyl in Europe + certain Asia + Africa 2019-06-12
1 2 3 ... 97 98 99  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSBNL] Life-Sciences-Benelux.com – The Business Web Portal 600x86px

» top